SEPTInvestingStart Free

MGNX 10-Q: SEC filing

MacroGenics

Filed with the SEC on · accession 0001125345-26-000073

MGNX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -1.3% by the first close after the filing.

Summary of the filing

MacroGenics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue from collaborative and royalty agreements.

For details, click here →How to read a 10-Q →

Key details

FilerMacroGenics, Inc.

How MGNX stock reacted

Close before

$2.32

Nov 11, 2026

First close after

-1.29%

$2.29

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MGNX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MGNX?

Click here

Frequently asked questions

What did MGNX file with the SEC on Nov 12, 2026?

MGNX filed a 10-Q (SEC filing). MacroGenics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue from collaborative and royalty agreements.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did MGNX stock react to this filing?

MGNX closed at $2.32 before the filing and $2.29 on Nov 12, 2026 (-1.29%).

Other MGNX SEC filings

Get alerts when MGNX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MGNX overviewMGNX analysisMGNX newsLatest SEC filings